Read + Share
Hige S, Aoki K, Nakamoto D, Flaherty JF, et al. Real-world safety and effectiveness of tenofovir alamenamide for 144 weeks in
Japanese patients with chronic hepatitis B. J Viral Hepat 2024 Jan 1. doi: 10.1111/jvh.13912.
PMID: 38163911
|
 |
|
Hige S, Aoki K, Nakamoto D, Flaherty JF, et al. Real-world safety and effectiveness of tenofovir alamenamide for 144 weeks in
Japanese patients with chronic hepatitis B. J Viral Hepat 2024 Jan 1. doi: 10.1111/jvh.13912.
PMID: 38163911
|
|
|
|